Orbital Therapeutics
Expanding RNA medicines to more tissues, more diseases, and more patients.
26 employees · est. 2022 · Cambridge, United States
Vico Therapeutics
Our mission is simple… bring innovative RNA modulating therapies to patients with severe, genetic neurological diseases.
49 employees · est. 2019 · Leiden, The Netherlands
Vico Therapeutics is the older company (2022 vs 2019).
Side-by-Side Comparison
| Metric | Orbital Therapeutics | Vico Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2019 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Leiden, The Netherlands |
| Employees | ||
| Employees | 26 | 49 |
| Industry | ||
| Industry | Not tracked yet | Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Acquired | Series B |
| Total Funding | ||
| Total Funding | $1.77B | $108.30M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | RNA Medicine Development, Immunotherapy Design, Integrated RNA Platform, Clinical Trials, Research and Development | Development of Antisense Oligonucleotide Therapies, Clinical Trials for Genetic Disorders, Genetic Intervention Research |
| Target Customers | ||
| Target Customers | Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Companies, Research Institutions | Patients with Rare Neurological Diseases, Caregivers, Advocacy Communities, Healthcare Providers specializing in Neurology |
| Taxonomy | ||
| Taxonomy | RNA MedicinesCell ReprogrammingAutoimmune DiseasesB Cell DepletionProgrammable TherapiesTargeted Delivery +8 | RNA Modulating TherapiesGenetic Neurological DiseasesSpinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington’s DiseaseAntisense Oligonucleotides +8 |
| Website | ||
| Website | orbitaltx.com | vicotx.com |
About Orbital Therapeutics
Orbital Therapeutics, founded in 2022 and headquartered in the United States, stands at the forefront of innovation in the burgeoning field of RNA medicines. The company's mission is succinctly encapsulated in its slogan: "Expanding RNA medicines to more tissues, more diseases, and more patients."...
About Vico Therapeutics
Vico Therapeutics is making strides in the Health Care and Pharmaceutical industries by focusing on innovative RNA modulating therapies for severe genetic neurological diseases. Founded in 2019 and based in The Netherlands, the company aims to address conditions like spinocerebellar ataxia types 3 a...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Orbital Therapeutics and Vico Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Orbital Therapeutics or Vico Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Orbital Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Orbital Therapeutics on 11 Mar 2026, and Vico Therapeutics on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
